with/in/sight presenter and Yaffe Lab postdoc Dr. Tiffany Emmons took this image as part of a project studying the features of different tumor cells that survive chemotherapy treatment. Note that some cells bear multiple nulcei (bright orange and pale blue). See more at the KI Image Awards Archive.
Lethal weapons against cancer: Targeting cell death and injury pathways to eradicate tumors
Thursday, May 8, 2025, 5:30 – 7:30 p.m.
Koch Institute at MIT
500 Main Street, Building 76
Cambridge, MA 02139
Register to attend in person on Eventbrite
Register to attend online on Zoom
Cancer treatments kill tumor cells—does it really matter how?
Cells can die or signal injury via several different biological processes or pathways, and research increasingly suggests that the particular mechanism activated by a cancer therapy can significantly affect treatment outcomes.
Join us as Koch Institute researchers explain how they are leveraging specific cell injury and cell death pathways to take out tumors using new approaches to improve immunotherapy response and target aggressive, metastatic cancer cells.
Featuring
Whitney Henry, PhD
Assistant Professor of Biology
Michael B. Yaffe, MD, PhD
David H. Koch Professor of Science
Professor of Biology and Biological Engineering
Director, MIT Center for Precision Cancer Medicine
Tiffany Emmons, PhD
Postdoctoral Associate, Yaffe Laboratory
Co-hosted by the MIT Club of Boston and the Koch Institute.
Related News
Welcome, Professor Henry!
MIT Koch Institute
Making Sense of Cell Fate
MIT News